Overview
Do NSAIDS or Executing Exercise Decrease Local Erythema, Site Swelling & Pain After INoculation
Status:
Completed
Completed
Trial end date:
2018-12-01
2018-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this clinical investigation is to evaluate the efficacy and immunologic effects of a non-pharmacological exercise intervention (push-ups) compared to an oral NSAID (ibuprofen) and an oral placebo to decrease local injection site inflammation symptoms of delayed pain, erythema, and edema and any impact on serologic antibody immune response after influenza vaccine receipt.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Womack Army Medical CenterCollaborator:
United States Department of DefenseTreatments:
Ibuprofen
Vaccines
Criteria
Inclusion Criteria:Must:
1. Be Active Duty Service Members.
2. at least 18 years of age or older.
3. Be requiring and eligible for inactivated influenza vaccine receipt.
4. Be willing and able to complete the study protocol requirements.
5. Have a current Flu Screening Form with medical clearance to receive the influenza
vaccination.
Exclusion Criteria:
Must Not:
1. Have already received influenza vaccine for the current season.
2. Have received any type of vaccine in the previous 72 hours.
3. Be on a medical profile resulting in current profile exemption from Physical Training
of Upper 2 or Upper 3. (Upper extremity injury or illness)
4. Have preexisting symptoms of injury or infection or other local symptoms that would
interfere with site assessment.
5. Be pregnant.
6. Have a history of allergy, intolerance, stomach bleeding or other medical exclusion
for ibuprofen.
7. Have a history of stroke or coronary artery disease, such as uncontrolled high blood
pressure or abnormal heart beat.
8. Has taken any topical or oral pain medications from the following medication classes
in the past 24 hours prior to the start of the study: oral acetaminophen, opioids,
tramadol, nonsteroidal anti-inflammatory drug (NSAID) or acetylsalicylic acid (ASA) or
topical pain relievers or counterirritants of menthol, methyl salicylate, camphor
menthols, and capsaicins.
9. Have any chronic or acute illness or treatment causing immunological suppression such
as current oral steroid therapy, malignancy or chemotherapy or lung disease. (not
including controlled asthma)
10. Currently participating in any other study
-